IFRS Financial statements | A Aviva viva p plc lc A An nn nu ua al r l re ep po orrt a t an nd a d ac cc co ou un nt ts 2 s 20 01 14 4 151 151 7 Details of expenses This note gives further detail on the items appearing in the expenses section of the consolidated income statement.
2014 2013 Continuing operations m m Claims and benefits paid Claims and benefits paid to policyholders on long-term business Insurance contracts 10,085 11,899 Participating investment contracts 4,431 5,089 Non-participating investment contracts 27 61 Claims and benefits paid to policyholders on general insurance and health business 5,917 6,082 20,460 23,131 Less: Claim recoveries from reinsurers Insurance contracts 933 975 Participating investment contracts 53 63 Claims and benefits paid, net of recoveries from reinsurers 19,474 22,093 Change in insurance liabilities Change in insurance liabilities note 41 5,890 2,396 Change in reinsurance asset for insurance provisions note 41 320 97 Change in insurance liabilities, net of reinsurance 5,570 2,493 Change in investment contract provisions Investment income allocated to investment contracts 2,629 4,406 Other changes in provisions Participating investment contracts note 42 3,218 2,244 Non-participating investment contracts 678 409 Change in reinsurance asset for investment contract provisions 7 9 Change in investment contract provisions 6,518 7,050 Change in unallocated divisible surplus note 46 3,364 280 Fee and commission expense Acquisition costs Commission expenses for insurance and participating investment contracts 2,103 2,264 Change in deferred acquisition costs for insurance and participating investment contracts 59 184 Deferrable costs for non-participating investment contracts 63 82 Other acquisition costs 828 872 Change in deferred acquisition costs for non-participating investment contracts 38 93 Investment income attributable to unitholders 112 347 Reinsurance commissions and other fee and commission expense 304 319 3,389 3,975 Other expenses Other operating expenses Staff costs note 11b 848 841 Central costs and sharesave schemes 132 150 Depreciation 19 31 Impairment of goodwill on subsidiaries note 17 48 Amortisation of acquired value of in-force business on insurance contracts 32 37 Amortisation of intangible assets 81 81 Impairment of intangible assets 10 14 Integration and restructuring costs see below 140 363 Other expenses 773 701 2,035 2,266 Impairments Net impairment on loans 9 30 Net impairment on financial investments 1 2 Net impairment on receivables and other financial assets 5 3 32 Other net foreign exchange gains losses 53 78 Finance costs note 8 540 609 Expenses from continuing operations 40,834 33,174 Expenses from discontinued operations 3,127 Total expenses 40,834 36,301 Integration and restructuring costs Integration and restructuring costs from continuing operations were 140 million 2013: 363 million and mainly include 94 million of expenses associated with the Solvency II programme 2013: 79 million.
Compared to the prior year, integration and restructuring costs have reduced by 223 million principally driven by a significant reduction in transformation spend.
